A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults
Public ClinicalTrials.gov record NCT02100631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomized, Double-blind, Placebo-controlled Study in Older Adults to Assess Immunogenicity and Clinical Acceptability of a Single-dose of the Live Oral Cholera Vaccine Candidate PXVX0200 O1 Serotype Inaba Strain CVD 103-HgR
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Demonstrate that the vaccine offers protection based on antibody levels in older adults and is similar to antibody levels in adults aged 18-45 following vaccination with PXVX0200.
Study identification
- NCT ID
- NCT02100631
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 398 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 46 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2014 (Type not available)
- Primary completion
- Feb 2015 (Actual)
- Completion
- Jun 2015 (Actual)
- Last update posted
- Jun 28, 2023
2014 – 2015
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coastal Clinical Research | Mobile | Alabama | 36608 | — |
| Avail Clinical | DeLand | Florida | 32720 | — |
| Miami Research Associates | Miami | Florida | 33143 | — |
| Palm Beach Research Center | Palm Beach | Florida | 33409 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Johnson County Clin-Trials | Lenexa | Kansas | 66219 | — |
| Heartland Research | Wichita | Kansas | 67207 | — |
| Central Kentucky Research | Lexington | Kentucky | 40509 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| Boston University | Boston | Massachusetts | 02218 | — |
| Center for Pharmaceutical Research | Kansas City | Missouri | 64114 | — |
| St. Louis University | St Louis | Missouri | 63104 | — |
| Coastal Carolina Research | Mt. Pleasant | South Carolina | 29464 | — |
| Research Across America | Dallas | Texas | 75234 | — |
| Jean Brown Research | Salt Lake City | Utah | 84124 | — |
| University of Vermont | Burlington | Vermont | 05405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02100631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2023 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02100631 live on ClinicalTrials.gov.